Polar Capital Holdings PLC Castle Biosciences Inc Transaction History

Polar Capital Holdings PLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Dec 13, 2023	BUY	$19.47 - $28.49 $260,859 - $381,709	13,398 New	13,398 $304,000
Q4 2022 Feb 14, 2023	SELL	$18.08 - $30.0 $643,412 - $1.07 Million	-35,587 Reduced 72.65%	13,398 $315,000
Q2 2022 Aug 15, 2022	BUY	$16.0 - $45.99 $64,000 - $183,960	4,000 Added 8.89%	48,985 $1.08 Million
Q4 2021 Feb 14, 2022	BUY	$39.06 - $67.58 $316,659 - $547,871	8,107 Added 21.98%	44,985 $1.93 Million
Q3 2021 Nov 15, 2021	BUY	$60.13 - $77.6 $488,075 - $629,879	8,117 Added 28.22%	36,878 $2.45 Million
Q2 2021 Aug 16, 2021	BUY	$50.07 - $76.78 $1.44 Million - $2.21 Million	28,761 New	28,761 $2.11 Million

171

25.5M

511K

130K

Ticker CSTL
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 26,297,000
Market Cap $750M
Description
Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company als...

Get notified when there are updates to the investment portfolio of Polar Capital Holdings PLC, based on Form 13F filings with the SEC.

Stay updated on Polar Capital Holdings PLC with notifications on news.